As of 4:00pm ET
| +0.49 / +1.49%|
The 4 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 56.50, with a high estimate of 92.00 and a low estimate of 41.00. The median estimate represents a +69.82% increase from the last price of 33.27.
The current consensus among 6 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.